E.S. Vesell

619 total citations
21 papers, 517 citations indexed

About

E.S. Vesell is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, E.S. Vesell has authored 21 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in E.S. Vesell's work include Pharmacogenetics and Drug Metabolism (5 papers), Metabolism and Genetic Disorders (4 papers) and Diet and metabolism studies (3 papers). E.S. Vesell is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Metabolism and Genetic Disorders (4 papers) and Diet and metabolism studies (3 papers). E.S. Vesell collaborates with scholars based in United States and Germany. E.S. Vesell's co-authors include Barry Dvorchik, Gabriel A. Kyerematen, J.D. deBethizy, G. Thomas Passananti, Carol A. Shively, James P. Fabisiak, D. E. Rannels, John G. Page, Mark Seaton and Alexander G. Karczmar and has published in prestigious journals such as Cancer, Pharmacological Reviews and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

E.S. Vesell

21 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.S. Vesell United States 13 185 143 98 81 69 21 517
Norman R. Eade Canada 10 142 0.8× 97 0.7× 73 0.7× 68 0.8× 44 0.6× 19 512
Joseph J. McPhillips United States 15 219 1.2× 58 0.4× 117 1.2× 164 2.0× 36 0.5× 25 613
Blake B. Coldwell Canada 15 120 0.6× 145 1.0× 54 0.6× 100 1.2× 49 0.7× 49 587
A. Hayes United Kingdom 8 162 0.9× 109 0.8× 44 0.4× 93 1.1× 64 0.9× 15 599
C D Klaassen United States 11 108 0.6× 135 0.9× 90 0.9× 63 0.8× 141 2.0× 17 453
P. V. Colthup United Kingdom 9 90 0.5× 72 0.5× 156 1.6× 65 0.8× 86 1.2× 9 487
Toshiaki Amamoto Japan 14 162 0.9× 90 0.6× 40 0.4× 47 0.6× 72 1.0× 21 578
Giorgio Stramentinoli Italy 19 299 1.6× 136 1.0× 120 1.2× 88 1.1× 237 3.4× 46 1.2k
C. John Parli United States 15 155 0.8× 160 1.1× 56 0.6× 105 1.3× 57 0.8× 30 513
Françoise Beaugé France 19 296 1.6× 70 0.5× 192 2.0× 199 2.5× 40 0.6× 56 805

Countries citing papers authored by E.S. Vesell

Since Specialization
Citations

This map shows the geographic impact of E.S. Vesell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.S. Vesell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.S. Vesell more than expected).

Fields of papers citing papers by E.S. Vesell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.S. Vesell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.S. Vesell. The network helps show where E.S. Vesell may publish in the future.

Co-authorship network of co-authors of E.S. Vesell

This figure shows the co-authorship network connecting the top 25 collaborators of E.S. Vesell. A scholar is included among the top collaborators of E.S. Vesell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.S. Vesell. E.S. Vesell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seaton, Mark, Gabriel A. Kyerematen, & E.S. Vesell. (1993). Rates of excretion of cotinine, nicotine glucuronide, and 3-hydroxycotinine glucuronide in rat bile.. Drug Metabolism and Disposition. 21(5). 927–932. 13 indexed citations
2.
Romano, Paula J., et al.. (1992). Do histocompatibility antigens antigence influence the risk of head and neck carcinoma?. Cancer. 69(9). 2327–2332. 17 indexed citations
3.
Miele, Monica, E.S. Vesell, W. Christopher Ehmann, et al.. (1992). Hormonal and immunological regulation of 2′,5′-oligoadenylate synthetase activity in human peripheral blood mononuclear cells. Clinical Immunology and Immunopathology. 65(2). 183–192. 3 indexed citations
4.
Vickers, Florence F., et al.. (1989). On the antipyrine test in laboratory animals. Studies in the dog and monkey.. Drug Metabolism and Disposition. 17(2). 160–165. 17 indexed citations
5.
Vesell, E.S., et al.. (1989). Brief maternal deprivation of rats reduces hepatic mixed function oxidase activities. Life Sciences. 45(19). 1755–1761. 2 indexed citations
6.
Vesell, E.S., et al.. (1989). Hormonal regulation of the developmental pattern of epoxide hydrolases. Biochemical Pharmacology. 38(4). 603–610. 18 indexed citations
7.
Karczmar, Alexander G., et al.. (1989). Bernard B. Brodie and the Rise of Chemical Pharmacology. The Annual Review of Pharmacology and Toxicology. 29(1). 1–22. 11 indexed citations
8.
Kyerematen, Gabriel A., et al.. (1988). Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay.. Drug Metabolism and Disposition. 16(1). 125–129. 57 indexed citations
9.
Kyerematen, Gabriel A., et al.. (1988). Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro.. Drug Metabolism and Disposition. 16(6). 823–828. 80 indexed citations
10.
11.
Fabisiak, James P., E.S. Vesell, & D. E. Rannels. (1987). Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. II. Receptor-independent accumulation of beta adrenergic antagonists and other cationic amphiphilic drugs in lamellar bodies.. Journal of Pharmacology and Experimental Therapeutics. 241(2). 728–735. 7 indexed citations
12.
Fabisiak, James P., E.S. Vesell, & D. E. Rannels. (1987). Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. I. Analysis, characterization and regulation of specific beta adrenergic receptors.. Journal of Pharmacology and Experimental Therapeutics. 241(2). 722–727. 30 indexed citations
13.
Vesell, E.S.. (1978). Intraspecies differences in frequency of genes directly affecting drug disposition: the individual factor in drug response.. Pharmacological Reviews. 30(4). 555–563. 4 indexed citations
14.
Connor, John D., et al.. (1978). Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitor.. Drug Metabolism and Disposition. 6(2). 164–168. 14 indexed citations
15.
Vesell, E.S., et al.. (1973). Relationship between Plasma Antipyrine Half-Lives and Hepatic Microsomal Drug Metabolism in Dogs. Pharmacology. 10(6). 317–328. 46 indexed citations
16.
Vesell, E.S., et al.. (1972). Effects of Chronic Prazepam Administration on Drug Metabolism in Man and Rat. Pharmacology. 7(3). 197–206. 15 indexed citations
17.
Vesell, E.S., et al.. (1972). Differential Effects of GPA 1851 on Hepatic Microsomal Drug Metabolism Dependent on Dosage and Time of Sacrifice. Pharmacology. 8(4-6). 217–221. 8 indexed citations
18.
19.
20.
Vesell, E.S.. (1968). Factors Altering the Responsiveness of Mice to Hexobarbital. Pharmacology. 1(2). 81–97. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norman R. Eade Breakdown of academic impact, for papers by Joseph J. McPhillips Breakdown of academic impact, for papers by Blake B. Coldwell Breakdown of academic impact, for papers by A. Hayes Breakdown of academic impact, for papers by C D Klaassen Breakdown of academic impact, for papers by P. V. Colthup Breakdown of academic impact, for papers by Toshiaki Amamoto Breakdown of academic impact, for papers by Giorgio Stramentinoli Breakdown of academic impact, for papers by C. John Parli Breakdown of academic impact, for papers by Françoise Beaugé
Rankless by CCL
2026